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ABSTRACT 
A large number of cell clones were isolated which produced 
different amounts of extracellular plasminogen activator. These 
clones were identified and selected by use of an overlay medium 
containing casein and plasminogen. All cells obtained by this 
method arose from a high passage cell line (BHK-2l/N) which had 
been originally cloned from BKH-2l/C13 cells. 
These cloned isolates from BHK-2l/N were characterized with 
respect to their growth rates and efficiencies of plating in soft 
agar and on plastic surfaces. No correlations were found between 
any of these growth properties and the amounts of extracellular 
plasminogen activator as detected in serum-free cell culture media. 
A plasminogen activator which was produced by a high passage 
hamster kidney cell line (Hpa-6) was characterized biochemically. 
The enzyme was found to be inhibited by diisopropylfluorophosphate 
and therefore was considered a serine protease. Hpa-6 cell anti-
vator was also found to react with plasminogen in a manner which was 
indistinguishable from the action of urokinase on the proenzyme. 
Evidence was obtained which suggests that the activator can hydrolyze 
either of the two molecular forms of plasminogen, i.e., plasminogen 
with glutamic acid amino terminus or plasminogen with lysine amino 
terminus at a single position to yield active plasmin. The cellular 
localization of the Hpa-6 cell plasminogen activator was examined and 
the results obtained indicate that this activity was largely associ-
ated with the plasma membrane. 
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A large amount of the recent work in cell biology has been 
directed toward study of the neoplastic state at a cellular level 
and in this regard investigators have often examined the in vitro 
parameters of cell growth and/or behavior. In many of the reports 
cells have been classified as being "normal" or "transformed." 
Initially, the term transformed was used in reference to cells which 
had undergone a phenotypic change. For example, transformed was 
employed to designate cells which exhibited a loss of density-
dependent inhibition of growth 11,2], increased plating efficiencies 
on plastic surfaces [3] or the abilities to grow in suspension 
[4,5,6]. On the contrary, normal cells were reported to exhibit 
density inhibition 1l,2J, low efficiency of plating 13] and the 
inabilities to grow in suspension 14,5,6J. More recently transfor-
mation has also been reportedly accompanied by increased lectin 
agglutinability [7,8,9], lower levels of cyclic adenosine 3' 5' 
monophosphate [10], and the production and/or release of plasminogen 
activators [11,12]. 
The term transformed has often been used synonymously with the 
neoplastic state. In this regard, some of the early studies 
demonstrated that transformed cells were capable of proliferating 
in vivo or of forming metastatic lesions upon injection into suitable 
hosts. Such results led many investigators to assume that cells 
which were transformed were also neoplastic. However, recent reports 
have demonstrated that some normal cells may be tumorigenic under 
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certain conditions [13J and, likewise, some cells designated trans-
formed have been found incapable of forming tumors in nude mice 
[14,15J. In view of these newer findings, the previously accepted 
relationships between cellular phentotypic properties and the neo-
plastic state have been obscured and this review will consider 
these parameters separately. 
The terms normal and transformed will be used in this text to 
describe cells designated as such by the authors cited, but these 
terms must be qualified. It should be noted that the criteria or 
phenotypic traits which have been employed to distinguish normal and 
transformed have often varied with different investigators. Numerous 
reports have also shown that considerable variation may occur among 
the phenotypic characteristics exhibited by transformed cells I15,16, 
17,18] and such cells may possess only a few or even only one of the 
properties ascribed to transformed cells. Keeping in mind the 
possible problems inherent in the use of normal versus transformed 
these terms are of value to this text as employed to the extent that 
they merely designate cells which may possess differences in some of 
the parameters of in vitro growth or behavior. 
A number of the properties commonly ascribed to transformed 
cells have been shown to occur transiently following brief proteo-
lytic treatment of normal cells. This finding has led to 
speculation that some cells may release proteases which can affect 
cell growth and/or behavior 19,19]. It has also been shown that 
proteolytic enzymes (plasminogen activators) are in fact present 
in the culture fluids of some cells and it was suggested that 
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plasminigen activators and/or the plasmin generated by their action 
could affect cell growth or phenotypic properties (11,12,20,21]. 
This hypothesis and relevant information concerning plasminogen 
activator will be the focal point of the following review. 
I will first briefly describe the phenotypic characteristics 
employed to differentiate normal and transformed cells and will also 
provide evidence for or against the involvement of prot eases with 
these properties. Secondly, those cells which have been described 
and the possible involvement of the activator in cell growth or 
behavioral alteration will be discussed. Finally, the nature of 
plasminogen activator will be considered with emphasis on the 
physical and biochemical properties of those enzymes which have been 
examined. 
PHENOTYPIC PROPERTIES OF NORMAL AND TRANSFORMED CELLS 
INCLUDING EVIDENCE FOR OR AGAINST THE INVOLVEMENT 
OF PROTEASES IN THE EXPRESSION OF THESE 
CHARACTERISTICS 
Density Inhibition 
The term "density inhibition" refers to the cessation of the 
in vitro growth of normal cells which have been propagated under 
conditions where virutally all cells are in contact with others 
[1,2]. This state has been examined by a number of methods of which 
the determination of saturation density (i.e., maximum number of 
cells per unit surface area) has been most commonly reported [6,14, 
17]. Typically, normal cells have been shown to be density 
inhibited and reach finite saturation densities while transformed 
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d h d " . 11' 1" t . cells do not respon to t ose con 1t10ns or s1gna s presen 1n 
a dense population of cells and consequently continue to grow and 
increase in number (eyen though cell-cell contact has been achieved). 
The treatment of confluent cultures of mouse 3T3 cells 122J or 
chick embryo fibroblasts 123,24,25] with low concentrations (1-10 
ugm/ml) of trypsin or other proteolytic enzymes has been shown to 
stimulate their growth or temporarily release them from density 
inhibition. Thus, it was suggested that proteases may be involved 
in the loss of density inhibition and mechanisms by which proteases 
could affect this cellular property were proposed [26J. However, 
there have been many other so-called "serum factors,tt cellular 
products, and nutrient alterations which have been reported to 
release cells from density inhibition. Molecules such as pancreatic 
ribonuclease, digitonin, and hyaluronidase would seem to perform 
unrelated functions, yet all of these molecules have been reported 
to produce this effect [27J. In view of these observations events 
other than the release and action of proteolytic enzymes could 
account for the loss of density inhibition and the physiological 
basis for this phenomenon has yet to be determined. 
Efficiencies of Plating 
Efficiencies of plating have been commonly expressed as the 
percentage of cells which continue to grow and form colonies after 
sparse numbers of cells have been seeded into culture vessels [3]. 
Generally, normal cells such as hamster fibroblasts possess plating 
efficiencies of less than 1% while transformed cells or those 
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infected with oncogenic viruses have much higher efficiencies of 
plating. It has been suggested that cells release substances 
necesary to the continued growth of normal cells and that such 
molecules are diluted to ineffective levels when only a few cells 
are present in a relatively large quantity of growth medium 128J. 
The evidence which suggests an involvement of proteolytic enzymes 
in the above phenomena is scant. McIlhinney and Hogan 129] have 
shown that the proteolytic inhibitors, pepstatin, leupeptin, and 
tosylphenylchloromethylketone (TPCK) reduced the efficiency of 
plating of hamster kidney cells. The interpretation of these 
results was obscured by the fact that leupeptin and pepstatin 
inhibit trypsin-like enzymes while TPCK inhibits chymotrypsin. 
However, the concentrations of TPCK used in these studies were also 
found to decrease the rates of cellular protein synthesis. A 
further problem with the interpretation of these results stems from 
McIlhinney and Hogan's observation that the addition of leupeptin 
and pepstatin also resulted in an apparent decrease in cellular 
growth rates, but from the information they provided it was not 
possible to ascertain whether the inhibitors actually slowed the 
growth of individual cells or were toxic and killed cells. 
Cell Growth in Semisolid Suspension 
Normal cells will not grow when suspended in a medium made 
semisolid by the addition of agar or methylcellulose while a high 
percentage of transformed cells are able to form colonies under these 
conditions I4,5,6J. Previous results have suggested that the ability 
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to grow in suspension (loss of anchorage dependence) may correlate 
with a change in the internal organization or structure of actin 
containing microfilaments or microfilament sheaths 130]. Since the 
addition of trypsin or other proteases has also been reported to 
result in a change in the internal organization of microfilaments or 
cytoskeletal elements 131] it could be supposed that proteases also 
affect the abilities of cells to grow in suspension. Though this 
has not been tested directly, Ossowski et al. 132] reported that 
serum which had been depleted of plasminogen was less effective in 
supporting the growth of SV40 virus infected rat cells when 
suspended in medium which contained agar. 
Lectin Agglutinability 
As reviewed by Rapin and Burger [33], various plant lectins 
such as concanavalin A (Con A) and wheat germ agglutinin ac" capable 
of agglutinating cells, and some transformed cells have been shown 
to be aggregated by concentrations of lectin which are much lower 
than the amounts of lectin required to agglutinate norma.;. t:ells 
[7,8,9]. Nicholson [34] and Sachs et al. [35J have sugge:.;ted that 
the increased agglutinability of SV40 infected 3T3 cells or of 
hamster cells derived from tumors was due to an increased mobility 
of molecules within the plasma membrane. This membrane mobility was 
determined by the propensity of multivalent lectin molecules which 
were wound to surface moieties to be sequestered or form patches on 
the plasma membrane. However, other investigators employing mouse 
fibroblast, 3T3, SV40-3T3, or lymphoma cells reported that an 
increased mobility of molecules which bind lectin was not always 
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accompanied by increased agglutinability [36]. Thus, it does not 
appear that differences in lectin agglutinability can be explained 
by the differences in the mobility of membrane molecules, and other 
mechanisms or biological processes which could control the pheno-
typic expression of lectin agglutinability remain to be found. 
The treatment of a variety of cells with low concentrations 
of trypsin or other proteases has been shown to increase their 
agglutinability with some lectins [7,9,37]. Borek et al. [8] have 
observed that mouse 3T3 and rat cells incubated in the presence of 
cycloheximide exhibited increased agglutinability with Con A or 
wheat germ agglutinin. However, the addition of both cycloheximide 
and a proteolytic inhibitor, tosyllysylchloromethylketone (TLCK), to 
growth media did not result in an increase in lectin agglutinability. 
These and further experiments were interpreted by the authors to 
suggest that proteases are involved in membrane glycoprotein turn-
over and that the pertubation of this turnover could effect the 
organization or integrity of the cell surface as reflected by lectin 
agglutinability [8J. 
Intercellular Cyclic Adenosine 3' 5' Monophosphate 
As reviewed by Pastan and Johnson [10] many authors have sug-
gested that the intracellular levels of cyclic adenosine 3' 5' mono-
phosphate (c-AMP) may influence vitro cell growth and phenotype. 
Properties which have been reported to be influenced by cellular 
c-AMP levels include cell growth rate [38], density inhibition [38], 
progression through the cell cycle [39], growth in soft agar 
[10], and agglutinability by Con A [40]. Some of these characteris-
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tics are normally ascribed to transformed cells and in general such 
cells have been reported to possess lower levels of intracellular 
c-AMP [lQJ. Of possible significance to this review is the fact 
that intracellular levels of c-AMP have been shown to be decreased 
following the treatment of a variety of cells with trypsin I4l,42, 
43]. Since adenyl cyclase and 3' 5' phosphodiesterase may be 
membrane bound I44,45J it is possible that the proteolytic perturba-
tion of the cell membrane could also affect the activities of these 
enzymes. Yet, it is also possible that proteolytic action could 
affect the integrity of the membrane in such a way as to facilitate 
the leakage of the c-AMP into the culture fluid. 
Adhesion of Cells to the Surfaces 
on Which They Grow 
Work has also been completed which has shown that transformed 
cells may be more easily removed than normal cells from surfaces on 
which they are growing by either trypsin, chelating agents, or 
mechanical means I46,47,48,49]. It has been proposed that cells may 
adhere to a thin layer of serum molecules [50,51] or cell secreted 
molecules [52,53,54,55] both of which could coat the surfaces of 
Petri dishes. However, mechanisms by which cells control the 
tenacity of their attachment have not been clearly elucidated. 
It is a well-known fact that trypsin and other proteolytic 
enzymes can decrease the adherence of cells and it may be that 
proteases remove or cleave those molecules which function to "cement" 
cells to their substratum. However, Revel et al. [31] have ob-
served that the treatment of cells with proteolytic enzymes affected 
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the endoskeleton of these cells and this along with other findings 
led them to conclude that the decreased adherence following proteo-
lytic treatment was primarily due to the disruption or disorganiza-
tion of cytoskeletal microfilament or microtubular elements. 
Differences in the Surface Molecules of Normal 
and Transformed Cells 
A number of investigators employing a variety of techniques 
have compared the external surface glycoproteins of some normal and 
transformed cells. Originally, Hynes et al. 156] employed lactoper-
oxidase catalyzed surface iodination and identified a "large external 
transformation sensitive" (LETS) glycoprotein on the surface of 
hamster cells. Surface glycoproteins of similar size and which 
appear to be absent on transformed cells have also been detected by 
others employing different techniques 157,58,59,60,61,62,63,64]. 
The presence of these large external glycoproteins has been shown 
to be temperature-dependent when chick cells were infected with a 
temperature-sensitive mutant of Rous sarcoma virus 159,60,61,62] or 
when hamster cells were infected with temperature-sensitive polyoma 
virus [57]. Recent evidence has suggested that these large glyco-
proteins may be cross-linked to form a network or skeleton on the 
exterior surfaces of chick cells [65] but the biological function of 
these molecules remains to be established. At this point in time, 
the presence or absence of LETS glycoprotein or similar molecules 
in the cell surface has simply provided further evidence suggesting 
that structural differences may exist in the exterior plasma mem-
branes of normal and transformed cells. 
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LETS or similar glycoproteins have been shown to be removed 
from cell surfaces by proteases such as trypsin I19,56,66], plasmin 
I19,66J, collagenase, and a-chymotrypsin I66J. It is possible that 
the decreased amounts of LETS on some transformed cells may result 
from the action of proteases in culture fluids. Hynes et ale [67J 
have reported that the loss of LETS glycoprotein from the surfaces 
of chick cells transformed by temperature-sensitive mutants of Rous 
sarcoma virus was blocked when these cells were shifted to a 
temperature permissive for transformation and maintained in the 
presence of TLCK. However, the concentrations of TLCK which pro-
duced this effect were also found to inhibit protein synthesis in 
these cells by 28% and a number of other proteolytic inhibitors did 
not prevent the loss of LETS glycoprotein following the appropriate 
temperature shift. 
Other Phenotypic Properties 
Besides those in vitro growth or behavioral characteristics 
previously described, increased glucose transport [68,69], continued 
nuclear division in the presence of cytochalasin B [70], decreased 
serum requirement for growth 16], abilities to migrate into a wound 
or denuded area of the cell monolayer [71], increased growth rate 
[72], and the loss of the actin filament bundles [30] are some 
additional properties ascribed to transformed cells. These charac-
teristics have not been examined with a large number of cell types 
and for the most part, cellular mechanisms which are involved in 
their expression are not understood. For these reasons, these 
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properties will not be considered in more detail in this discussion. 
PLASMINOGEN ACTIVATOR IN CELL CULTURE FLUIDS 
Preface 
Observations of plasminogen activator production by cells 
cultured in vitro are not new to the field of cell biology. For 
example, Fisher [73] had described a fibrinolytic activity in sar-
coma cell cultures in 1925. The aforementioned evidence and 
subsequent speculation concerning a possible involvement of pro-
teases in producing or maintaining some of the phenotypic proper-
ties of transformed cells has renewed much interest and investiga-
tion into the role that plasminogen activators may play in the 
growth or expression of phenotypic properties of cultured cells. 
The term plasminogen activator has been used to describe those 
enzymes or molecules which proteolytically convert the proenzyme 
plasminogen to the active protease, plasmin. The use of this term 
should in no way be taken as an inference that the proteolytic 
actions of these activators are limited to the substrate plasmin and 
other yet unidentified proteins could be the de Facto substrates for 
these enzymes. It is also important to note that most authors have 
not distinguished between the occurrence of extracellular plasminogen 
activator, the release of activator, or its production. The terms, 
production and release, invoke two different possibilities to 
explain differences in amounts of extracellular activator. Since 
appropriate information usually was not provided, production and/or 
release will be used in combination in this section to prevent any 
erroneous conclusions about the occurrence of extracellular 
activator. 
Is Increased Extracellular Activator A 
Property of Transformed Cells? 
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Taylor et ala IIlJ have reported plasminogen activator activity 
in the culture fluids of high passage BHK-21/C13 cells. Those cells 
which produced and/or released increased amounts of the enzyme also 
possessed a number of properties commonly ascribed to transformed 
cells, namely, higher growth rates, increased plating efficiencies, 
increased lectin agglutinabilities and growth in soft agar. Work by 
Unkeless et ala [12] and Ossowski et ala [21] demonstrated that 
primary chick or mammalian fibroblasts which were infected and 
transformed with either DNA or RNA oncogenic viruses produced and/or 
released activators of plasminogen, while their normal non-infected 
counterparts or normal counterparts infected with cytopathic viruses 
did not. The occurrence of extracellular activator was found to be 
temperature-dependent when chick cells were infected with a 
temperature-sensitive mutant of Rous sarcoma virus [12]. These authors 
suggested that the occurrence of extracellular plasminogen activator 
was a qualitative and distinct difference observed with transformed 
cells. Similar findings were also reported by Goldberg [74] when he 
observed that chick fibroblasts transformed by RSV and Balb C/3T3 
cells transformed by mouse sarcoma virus, RSV, or SV40 virus all 
produced and/or released plasminogen activator. However, in his 
studies primary chick fibroblasts were found to produce and/or 
release detectable, albeit, low levels of the enzyme 174]. The 
detection of plasminogen activator in primary chick cell cultures 
indicates that the presence of the enzyme was not an exclusive 
property of transformed cells. 
Additional evidence suggesting a lack of correlation between 
plasminogen activator production and cell transformation has been 
reported by Mott et ala 175] when it was shown that normal mouse 
3T3, human WI-38, and WI-26 cell culture fluids possessed more 
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enzyme than their SV40 transformed counterparts. Equivalent amounts 
of the activator were measured in culture fluids from established 
and virus transformed Chinese hamster kidney cell lines. The 
production and/or release of plasminogen activator from Balb/C 3T3, 
SV40-transformed Balb/C 3T3 (clone SVT2) and transformation rever-
tants (density inhibited cells) of SVT2 cells have also been examined 
(R. Snyder, unpublished results). Amounts of activity in cell cul-
ture fluids were determined by use of an 1251 fibrin released assay 
[12] or alternately cultured cells were directly examined for extra-
cellular enzyme by overlaying pseudoclones (a defined number of 
cells on a small area of the Petri dish) with a mixture containing 
Eagle's Medium, plasminogen, denatured casein, and agarose. As 
determined by either method, the Balb/C 3T3 and SVT2 revertant 
clones, D3 and E2, released equivalent, if not greater amounts of 
activity than did transformed SVT2 cells. 
Though studies considered up to this point indicate that 
plasminogen activator production and/or release does not correlate 
with transformation the evidence reported is not conclusive. In 
this regard, the preceding reports with the exception of Taylor 
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et al. Ill] did not include phenotypic characterizations of those 
cells examined. More importantly, determinations of extracellular 
plasminogen activator were usually performed with cells which had 
never, or at least, not recently, been cloned and these cell popula-
tions could have consisted of individuals which differed greatly in 
their abilities to produce and/or release plasminogen activators. 
In further attempts to clarify a possible role for plasminogen 
activator in cell growth or behavioral modification, a number of 
investigators have attempted to correlate the presence of plasminogen 
activator with various phenotypic properties commonly ascribed to 
transformed cells. Pollack et al. 117] have studied cloned popula-
tions of SV40 transformed rat cells and concluded that those cells 
which released the largest amounts of activator also possessed the 
greatest abilities to grow in a semi-solid medium containing methyl-
cellulose. However, no differences in the growth rates or saturation 
densities of those cloned populations were found. In contrast to 
the observation of Pollack et al., the amounts of extracellular 
activator detected with either cloned populations of human fibrosar-
coma cells [76] or cloned isolates of RSV transformed chick cells 
[77] have been shown not to correlate with their abilities to grow 
while suspended in semisolid media. In this regard, some cloned 
populations from both. cell types produced and/or released relatively 
low levels of activator yet grew very well in suspension. Further 
examinations of the cloned fibrosarcoma cells revealed that the 
saturation densities of those cell populations which possessed low 
levels of extracellular activator did not differ from those of cells 
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possessing high levels of extracellular enzyme [76J. Recently, 
Gallimore et al. 115J have studied cloned isolates of rat cells 
transformed by adenovirus and found that all of these transformed 
clones produced and/or released amounts of activator which were 
much greater than the amounts of extracellular enzyme possessed by 
cultures of non-infected rat cells. However, the transformed cells 
varied considerably with respect to their growth in methylcellulose 
suspension, saturation densities in 0.5% versus 5% calf serum, and 
growth rates in 0.5% versus 5% serum. 
The aforementioned results strongly suggest that extracellular 
plasminogen activator may not be involved in the expression of 
phenotypic properties commonly ascribed to transformed cells. 
However, all in vitro cell cultures may possess at least small 
amounts of plasminogen activator and it is possible that some yet 
unidentified conditions or events along with the action of plasmino-
gen activator may be necessary for the expression of some of the 
phenotypic alterations which have been described for transformed 
cells. 
Is Increased Extracellular Activator a 
Property of Neoplastic Cells? 
Since the original observation by Fisher [73], enzymes capable 
of converting plasminogen to plasmin have been measured in the cul-
ture fluids of a variety of cells derived from tumor tissue. 
Supernates from cultures of human sarcoma, mesothelioma, malignant 
melanoma [78J and neuroblastoma cells 179] all contained significant 
amounts of the activator. However, results from studies which have 
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investigated cloned populations of cells suggest that plasminogen 
activator production is not a general phenomena common to all cells 
derived from tumor tissue. In one case, only three out of six 
clones of cells derived from rat ovarian tumors were reported to 
possess detectable amounts of extracellular activator 180J. Like-
wise, as previously described, a variability in the amounts of 
extracellular activator among clones of cells isolated from a human 
fibrosarcoma cell line has also been reported l76]. 
In a different approach researchers have attempted to relate 
the amounts of plasminogen activator produced and/or released by 
cultured cells with their abilities to form tumors upon injection 
into suitable hosts. Jones et al. l76] have shown that all cloned 
isolates of human fibrosarcoma cells which possessed large amounts 
of extracellular activator were also capable of proliferating in 
vivo and forming tumors upon injection into immunosuppressed 
hamsters. However, the cloned isolates which possessed relatively 
low levels of extracellular activator also formed tumors under 
these conditions. It is important to note that the tumors formed 
by the fibrosarcoma cells grew rapidly, eventually killed their 
hosts, possessed human karyotypes and were determined to be fibro-
sarcomas by histological examinations. Work reported with cloned 
rat cells which had been transformed with adenovirus has shown that 
some cells which release increased amounts of activator are incapable 
of forming metastasizing tumors after injection into syngeneic rats 
or nude mice lIS]. In other experiments, Laug et al. [81] have 
demonstrated that HeLa cell cultures contain small amounts of 
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activator yet these cells were shown to be capable of forming 
tumors in immunosuppressed hamsters. The results of these tttumori-
genicity" experiments suggest that extracellular plasminogen 
activator may not be an absolute correlate to the neoplastic state, 
yet such studies are difficult to compare and evaluate since differ-
ent test animals were employed for tumorigenicity determinations and 
the criteria upon which a growth was determined to be a tumor 
differed. 
With yet other experimental approaches, authors have provided 
evidence supporting the hypotheses that plasminogen activator may be 
involved in neoplasia. Jones et al. £76] observed that cells ob-
tained from fibrosarcoma explants released large amounts of activa-
tor even though the cloned cells which had been introduced to form 
these tumors had previously possessed small amounts of extracellular 
activity. These authors concluded that the in vivo growth of these 
cells induced the release of increased amounts of plasminogen 
activator. Their conclusion was not unreasonable in that the ex-
planted cells which released large amounts of activator were cloned 
and found to be of human origin and not of the host animal, i.e., 
hamsters. Secondly, experiments were performed which tended to rule 
out the possibility that tumor growth selected for cells which 
released large amounts of activator and were already present in the 
inoculum. Mak et al. £82J have shown that dihydrotestosterone 
specifically induced the release of activator from an androgen 
dependent mammary carcinoma (Sionogi SC-115) cell line. Christman 
et al. I83] have also demonstrated that a loss of tumorigenic 
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potential occurred concomitant with a decrease in activator release 
when a Brdu (5-bromo-2-deoxyuridine) sensitive clone of IDouse mela-
noma cells was cultured in the presence of Brdu. This decrease in 
tumorigenicity could not he explained by a loss of viability in the 
presence of Brdu and the alterations due to Brdu could be reversed 
upon its removal from the medium. Christman et al. I83] have not 
offered any suggestions as to how Brdu specifically affects the 
production of plasminogen activator or the ability of these cells to 
form tumors in host animals. 
A General Phenomena of Cells In Vitro 
As mentioned previously, a variety of normal cells which were 
neither virus transformed nor obtained from tumor tissues have also 
exhibited release of plasminogen activators and this list can be 
extended. Primary cultures of human embryonic kidney [84], monkey 
kidney [85], rat embryo I17] and chick fibroblasts [74] all have been 
reported to release and/or produce detectable amounts of the pro-
tease. Secondary cultures of human diploid kidney, heteroploid kid-
ney, and lung cells have also been shown to possess supernate 
activity [84]. Since the presence of this protease in cell culture 
fluid may be a ubiquitous phenomena it is appropriate to discuss 
briefly some possibilities for its biological function. 
There are changes in the cell membrane which correspond to the 
cell's phase in the growth cycle and some of these changes may be a 
result of a proteolytic action. Balb C/3T3 cells have been found to 
become highly agglutinahle with Con A or wheat germ agglutinin 
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during mitosis f37,86J. The 250,000 dalton LETS glycoprotein, as 
described by Hynes and Humphryes 156J, was not present in the 
membrane of normal cells' which were treated with colchicine and 
arrested in mitosis f191. Cells may round up and become less 
adherent during mitosis 187J. Lower levels of c-AMP have also been 
shown to occur with 3T3 188J or Chinese hamster ovary (CRO) cells 
f89] during mitosis and into early Gl phase and this may also 
reflect proteolytic surface alterations. 
If plasminogen activator was responsible for some of these 
cell cycle dependent surface changes it would be reasonable to 
suppose that the protease should only act during specific periods 
in the cell cycle. However, this is probably not the case since 
the activator appears to be continuously present in the fluids of 
many unsynchronized cell cultures. A second means by which the 
action of plasminogen activator could be involved in transient cell 
surface alteration can also be proposed. It is possible that the 
activator continuously reacts with surface material and that the 
cell could regulate membrane alterations by controlling the synthe-
sis and replacement of those surface molecules which serve as 
substrate for the protease. 
Whether plasminogen activator can act directly on the cell 
surface is not known. Attempts to detect loss of cell surface 
material following the addition of crude supernates which contained 
plasminogen activator have been unsuccessful I66,83J. If the activa-
tor does function on a cell surface component, it is possible that 
such substrate molecules would competitively inhibit the activity of 
plasminogen activator. No inhibition of the protease was observed 
when supernates of RSV transformed chick cells were mixed with 
homogenates of primary chick cells and assayed oy l25I_fibrin 
release I90J. When nigh passage BHK-2l/C13 cells (which possessed 
large amounts of extracellular activator) were co-cultivated with 
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low passage cells (which possessed small amounts of extracellular 
activator) very little plasminogen activator could be measured Ill]. 
This was interpreted to suggest that the enzyme was binding to some 
substrate on the surfaces of low plasminogen activator producing 
cells and that this interaction resulted in an apparent decrease in 
measurable enzyme. 
Plasmin and Its Possible Effects 
Since plasminogen activators convert plasminogen to the active 
enzyme, plasmin, the possible action of plasmin in cell cultures 
should also be considered. The chromatography of serum on lysine-
substituted Sephorose has been employed to free serum of plasminogen 
[91] and these sera have been utilized in attempts to identify those 
growth and behavioral characteristics which may require the action 
of plasmin [32,92]. The ability of SV40 transformed hamster cells 
to grow in soft agar was reported to be decreased when serum 
depleted of plasminogen was added to the media I32]. Sera which 
were more efficient at promoting fibrinolysis with added cellular 
activator also were found to increase the efficiencies of colony 
formation when added to SV4Q transformed rat cells suspended in 
Methocel I17J. These results strongly suggest that the action of 
plasmin may be involved in the expression of this characteristic. 
However, as previously mentioned, some cloned RSV infected chick 
[77] and human fibrosarcoma cells {76] which exhibited very little 
extracellular activator activity grew relatively wel~ while sus-
pended in semisolid media. It is possible that the low levels of 
activator released by these cells could activate a quantity of 
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plasmin which would be sufficient to produce some required alteration. 
Studies with SV40 transformed hamster cells have shown no 
differences in growth rates in media supplemented with plasminogen 
depleted sera {32]. Similarly, no differences in growth rates, 
saturation densities or glucose transport were observed when RSV 
transformed chick cells were grown in plasminogen depleted sera {92]. 
It has also been reported that the morphological properties of 
SV40 transformed hamster fibroblasts were dependent upon the sera in 
which these cells were grown {93]. These morphological alterations, 
which consisted of an initial rounding of cells and their subsequent 
detachment were promoted by the addition of sera which would produce 
relatively high levels of fibrinolysis when mixed with activator from 
these cells (93J. The morphological changes which were noted for 
SV40-transformed hamster cells were prevented when sera depleted of 
plasminogen were employed. Likewise, a decrease in adherence which 
has been reported for RSV-CEF cells was also reversed by the addition 
of a high concentration of soy bean trypsin inhibitor (2.5 mg/ml) and 
other inhibitors of plasmin 194J. It is possible that the action of 
plasmin may alter cell morphology and/or adherence. 
THE NATURE OF PLASMINOGEN ACTIVATOR 
A Group of Enzymes With a Similar Action 
Primary and established cultures of human embryonic lung and 
kidney cells produce at least two antigenically distinguishable 
activators [84]. Some of the activity released by these cells was 
neutralized by antibody to human urokinase (a protease originally 
isolated from human urine). The percent of activity which was 
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neutralized with antibody to urokinase increased when kidney cell 
cultures were obtained from progressively older embryos [84]. These 
results could suggest that cells from the same organ and possibly 
of similar type may produce more than one activator. However, the 
cells employed in these studies were not cloned and it is likely 
that different cell types may have existed in the populations and 
that these different cell types each produced a different activator. 
The activator from a human melanoma cell line has been examined 
and the activity was found to correspond to two proteins which were 
reported to have molecular weights of 60,000 and 48,000 daltons as 
determined by SDS polyacrylamide gel electrophoresis 178]. However, 
it was not clear from the information present in this report whether 
these cells were a heterogeneous population or had been recently 
cloned. Aside from this consideration, it is also possible that the 
activators from human melanoma cells may have been antigenically 
related to urokinase and/or may have been enzymatically active 
peptides resulting from a partial degradation of urokinase. In this 
regard, the molecular weight of urokinase as purified from human 
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urine has been reported to be 54,000 daltons and treatment of this 
enzyme with trypsin or subtilisin has resulted in an active fragment 
of 36,000 daltons [95]. 
Plasminogen activators from cells other than those of human 
origin have also been characterized and multiple molecular forms of 
the enzyme have been found from cells of the same species. The 
activity from rat ovarian tumor cells has been reported to correspond 
to two species of large molecular weight (615,000 and 175,000 daltons) 
as determined by sucrose density gradient centriguation [80]. More 
recently, Chrisman et ale reported their results from immunological 
studies which employed antibody directed against a plasminogen 
activator released by SV40 transformed hamster cells [96]. The anti-
body was found to inhibit the enzyme released by primary or estab-
lished hamster lung cells, but had no effect when mixed with 
activator from either established heteroploid or primary hamster 
kidney cells. The antibody was also without effect when mixed with 
activators released by a number of other hamster cell lines which 
had been transformed by either RSV or chemical agents. 
It is not known whether the activators produced by cells from 
different animal species are similar or identical in structure. 
Christman et ale [96] have shown that antibody directed against a 
hamster plasminogen activator did not inhibit the activation of 
plasminogen when it was mixed with activators from murine or human 
cells. As noted above, these studies are not conclusive in that the 
antibody employed only reacted with one of the activators released by 
hamster cells. It is possible that there are a number of different 
groups or types of plasminogen activators some or all of which are 
produced by cells from a variety of species. It is also important 
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to emphasize that since there may be a large number of prot eases 
produced by cells which possess in common, the capabilities to 
activate plasminogen, in the future authors should attempt to char-
acterize or identify those particular enzymes which they are studying. 
Physical and Biochemical Properties 
The activator released by RSV infected chick embryo fibroblasts 
has been partially purified and characterized [90J 'and was reported 
to correspond to a single protein of 39,000 daltons as determined by 
SDS gel electrophoresis. The enzyme was found to be inhibited by 
p-tosyl-L-arginine methyl ester (TAME) and by high concentrations of 
L-arginine. The activator was also irreversibly inhibited by 
diisopropylflurophosphate (OFP) [90] and this was considered to be 
sufficient evidence to warrant its classification as a serine pro-
tease [97J. The use of OFP has also provided evidence that the acti-
vators produced and/or released by transformed hamster cells (50,000 
daltons) [98] and human melanoma cells (60,000 and 48,000 daltons) 
[78] are also serine proteases. 
The enzymatic specificities of some activators have also been 
examined. The proteolytic conversion of plasminogen to plasmin by 
the chick cell activator was assessed by SOS gel electrophoresis of 
the reaction mixture and the actions of the chick cell activator 
resulted in cleavage products which were indistinguishable from those 
resulting from the action of urokinase or streptokinase on plasminogen 
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[90]. Since urokinase and streptokinase (an activator produced by 
streptococcus) have been reported to hydrolyze an arginyl-valine 
peptide bond in the proenzyme [99J and the chick cell activator is 
inhibited by TAME and L-arginine it is possible that both of these 
enzymes have similar specificities and split plasminogen at the same 
position [90J. Since plasminogen contains a number of arginyl 
residues and the activators show a strict preference for only one of 
these, it is likely that the molecular conformation near the arginyl-
valine sequence is extremely important for substrate recognition by 
the activator. 
Christman et ale [83J have also reported that the activator 
released by hamster cells is specific for plasminogen and does not 
activate other zymogens such as trypsinogen, chymotrypsinogen or 
pepsinogen. It should also be pointed out that protein substrates 
other than plasminogen have not been reported for any of the 
activators described in this review. 
Intracellular Activator 
Plasminogen activator has been detected in Triton X 100 extracts 
of RSV transformed chick cells while normal (uninfected) cells did not 
contain measurable amounts of this intracellular activity [90]. 
These findings were interpreted by these authors to suggest that the 
increased amounts of extracellular enzyme present in cultures of RSV 
infected chick cells was the result of increased activator production 
rather than an increase in its release. However, it is also possible 
that the differences in intracellular activator observed with chick 
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and RSV-chick cells could be accounted for by differences in enzyme 
turnover in these two cell types. 
Jones et a1. 176] have found that the amounts of Triton X 100 
extractable or intracellular levels of plasminogen activator did not 
vary among cloned isolates of human fibrosarcoma cells even though 
there was considerable variation among these clones in the amounts of 
extracellular activator. These findings may suggest that the differ-
ences in extracellular activator observed among some cells could be 
accounted for by differences in its release and not by differences 
in its production. 
Unkeless et al. {90] reported that the activator produced by 
transformed chick cells was associated with crude lysosomal or micro-
somal fractions. However, a previous communication by this group had 
concluded that the occurrence of extracellular activator did not coin-
cide with any increase in lysosomal enzymes in the cell culture fluid 
lI2]. If both observations were correct this paradox would be diffi-
cult to reconcile. But the methods employed to determine the intra-
cellular localization were not very precise and consisted of a few 
steps of differential centrifugation. More recently, Quigley [100] 
has reported that the cellular activator from RSV transformed chick 
fibroblasts was associated with plasma membrane or plasma membrane-
like elements. In his communication he demonstrated that an activator 
from transformed chick cells co-purified with material which appeared 
to be membranous in electron micrographs and with molecules commonly 
reported to be associated with the plasma membrane. Christman et ale 
[83] have also investigated the localization of the activator in SV40-
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transformed hamster cells. The enzymatic activity could be localized 
in fractions enriched for plasma membranes following equilibrium 
sedimentation of plasma membrane ghosts in sucrose gradients. These 
authors also noted that plasminogen was rapidly activated when added 
to previously washed monolayers of transformed hamster cells, and 
this was interpreted as evidence for a cell surface localization of 
the enzyme. 
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CHAPTER II 
ISOLATION AND CHARACTERIZATION OF CLONED BHK CELLS WHICH RELEASE 
DIFFERENT AMOUNTS OF PLASMINOGEN ACTIVATOR 
by 
Robert W. Snyder and Douglas W. Hill 
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SUMMARY 
A large number of cell clones were isolated which produced 
different amounts of extracellular plasminogen activator. These 
clones were identified and selected by use of an overlay medium con-
taining casein and plasminogen. All cells obtained by this method 
arose from a high passage cell line (BHK-2l/N) which had been 
originally cloned from BKH-2l/C13 cells. 
These cloned isolates from BHK-2l/N were characterized with 
respect to their growth rates and efficiencies of plating in soft 
agar and on plastic surfaces. No correlations were found between any 
of these growth properties and the amounts of extracellular plasmino-
gen activator as detected in serum-free cell culture media. 
IHTRODUCTION 
Many previous experimental findings have implicated the involve-
ment of proteolytic enzymes in the alteration of cell growth or 
morphological properties. These have been reviewed by Hynes [1] and 
more recently by Roblin, Chou, and Black [2]. In light of this, the 
presence of a plasminogen activator (PA) in cell culture fluids had 
received much attention since activators of plasminogen have been 
shown to be proteases [3] and the action of the activator could 
generate plasmin from the zymogen which is present in serum. 
An early report suggested that in the in vitro production and/or 
release of the activator was a unique property of transformed cells 
[4]. It was proposed that the action of the enzyme may be responsible 
for some cell alterations necessary for the aberrant morphological or 
growth properties of transformed cells [1]. A number of investigators 
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have attempted to relate the ability to produce and/or release PA 
with various cell growth or physical properties. Taylor [5] has 
detected activators of plasminogen in serum-free culture fluids from 
high passage BHK-21-CI3 cells. Those cells which released increased 
amounts of the enzyme also possessed increased growth rates and 
plating efficiencies, the abilities to grow in soft agar suspension, 
and higher levels of lectin agglutinability. A correlation between 
high levels of extracellular activator and the abilities of cells to 
grow while suspended in methyl cellulose has also been described for 
clonal isolates of SV40-transformed rat embryo fibroblasts [6]. In 
other studies, Ossowski et ale [7], demonstrated a dependence upon 
the presence of plasminogen for the growth of SV40-transformed 
hamster cells in soft agar suspension. 
In this study, a large number of cell clones were isolated which 
released different amounts of PA. These cells were characterized in 
an attempt to correlate increased extracellular PA with a number of 
properties normally ascribed to transformed cells. The clones of 
cells were originally isolated by employing overlays containing 
plasminogen and casein [8,9]. This method allows detection of PA 
production through visualization of the caseinolysis which results 
from plasmin's action on denatured casein. The cell line utilized 
in these studies was originally cloned from BHK-21/CI3 cells. The 
BHK-21/N cells have previously been shown to possess high growth 
rates and high efficiencies of plating on plastic surfaces or in 
soft agar suspension. Furthermore, these cells can also be agglutin-
ated by relatively low levels of concanavalin A [5]. These cells 
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have been extensively "passaged" and were designated BHK-2l/N to 
distinguish them from BHK-2l/C13 cells. 
MATERIALS AND METHODS 
The BHK-2l/N cells employed in these studies have been previous-
ly described by Taylor IS]. These cells are high passage cells and 
were originally cloned from BHK-2l/C13. All cells were propagated in 
Eagles Minimal Essential Medium (MEM) (GIBCO) supplemented with 
either 5% or 10% calf serum (CS) (Flow Labs). Cells were routinely 
transferred one day after confluency. 
Isolation of Hpa and Lpa Cells and Frequencies of 
Activator Positive Colonies 
Cells were trypsinized, suspended in cold MEM + 10% CS, counted 
by aid of a hemocytometer, and the appropriate dilutions were made in 
culture media. Approximately 200 cells were added per 60 mm Falcon 
plastic Petri dish in 5 ml of medium. Following seven days of incuba-
tion at 37°C the macroscopically visible colonies were washed three 
times with calcium and magnesium deficient phosphate buffered saline 
(PD). The colonies were then overlayed with 3 ml of a mixture 
containing MEM, 0.4% w/v of agarose, 0.5% denatured skim milk and 
approximately 0.01 mg/ml of plasminogen. The human plasminogen had 
been purified by the methods of Deutsch and Mertz [10]. Following 
24 hours at 37°C the plates were examined and either caseinolytic or 
noncaseinolytic colonies were picked from the plates. This procedure 
was repeated at least once for all those Hpa and Lpa isolates used. 
The same protocol was also followed to determine the frequencies of 
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activator positive colonies. Following a 24-hour incubation with 
the plasminogen casein overlays the number of colonies demonstrating 
caseinolysis was determined for each plate. The overlays were then 
removed and cell colonies were stained and counted. 
Efficiencies of Plating on Plastic Surfaces 
Five ml of MEM + 10% CS which contained 200 cells were added per 
60 rom Falcon dish. The cultures were placed in a 37°C incubator and 
great care was taken to avoid disturbing them. Seven days later the 
medium was removed and cell colonies stained and counted. 
Efficiencies of Plating in Soft Agar 
The procedure was essential that of Macpherson and Montagnier 
[11]. The soft agar (0.3% agar in MEM + 10% CS) contained 200 cells 
per 60 rom Falcon Petri dish. Following eight days at 37°C the 
number of macroscopically visible colonies was determined for each 
culture plate. 
Determination of Plasminogen Activator 
in Cell Culture Fluids 
Confluent monolayers of cells were washed three times with PD. 
A 4.5 ml volume of MEM without calf serum was added per 25 cm2 
culture flask and removed after 18-22 hours of incubation at 37°C. 
Cell debris was removed by low-speed centrifugation and the super-
nates frozen. The activator was quantitated by use of an l25I-fibrin 
release assay or by fibrin clot lysis. The l25I-fibrin release 
assay was similar to that described by Unkeless et ale I4J with the 
following modifications: (1) the l25I-fibrin was clotted by addition 
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of 0.1 ml of 1 u/ml bovine thrombin (Park-Davis) in the presence of 
phosphate buffered saline for 2 hours at 37°C; (2) the assays were 
carried out in Costar multiwelled dishes (16 rom) with 0.1 ml of 
plasminogen (approximately 0.1 mg/ml), 0.1 ml of 0.1 M Tris (pH 8.1), 
and 0.1 ml of activator preparation in each well. The fibrin clot 
lysis assay was essentially that of Taylor I5J with the following 
modifications: (1) plasminogen was added to 0.4% human fibrinogen for 
a final concentration of approximately 0.01 mg/ml; (2) the cell 
supernates or dilutions thereof in PD were added to equal volumes of 
fibrinogen, clotted, and incubated at 37°C. The greatest dilution 
which yielded clot lysis was then determined after 24 hours of incu-
bat ion. 
RESULTS 
Isolation of Cells Producing Different 
Amounts of Activator 
When colonies of BHK-2l/N cells were overlayed with casein and 
plasminogen, both activator producing (positive) and non-producing 
(negative) colonies were detected. The differences observed for 
plasminogen activator production did not appear to correlate with 
colony size. However, only large negative colonies or small positive 
colonies were selected from these plates. Cells chosen from positive 
colonies were designated Hpa (high plasminogen activator) while those 
from negative colonies were designated Lpa (low plasminogen act iva-
tor). As shown in table 1, the Hpa isolates contained a high fre-
quency of cells which were capable of forming activator positive 
Table 1. BHK-21/N, Hpa, and Lpa cells: frequencies of activator positive colonies and 
relative amounts of activator in serum-free cell culture fluids. 
Activator Frequency of Reciprocal of 
Serial positive per activator greatest dilution 
Cell passage total colony positives demonstrating % of 125I-fibrin 
isolate level number colonies fibrino1~sis released 
BHK-21/N 39 210/938 0.224 1 ND 
Hpa-1 16 1476/1476 1.000 32 ND 
Hpa-1 20 ND ND 16 78 
Hpa-1 27 1017/1024 0.993 16 72 
Hpa-2 4 1056/1056 1.000 32 ND 
Hpa-4 9 1327/1327 1.000 32 ND 
Hpa-6 1 480/486 0.988 32 ND 
Lpa-1 1 192/1206 0.159 No Lysis ND 
Lpa-2 1 185/917 0.202 1 ND 
Lpa-4 11 10/1440 0.007 No Lysis 0 
Lpa-5 11 51/1375 0.037 No Lysis 0 





Table 1 (continued) 
a. NO signifies that the data were not obtained. 
b. Passage levels for BHK-2l/N represents the number of serial passes since the initiation of 
these studies. 
c. Passage levels for Hpa and Lpa isolates represent the number of serial passes since the 




colonies. Likewise, the Lpa populations were enriched with cells 
which yielded activator negative colonies. However, populations of 
cells which would consistently yield only positive or negative 
colonies during extended serial passage were never isolated. 
The amounts of plasminogen activator present in serum-free 
culture fluids from either Hpa or Lpa cells are also shown in table 
1. The supernates of Hpa cell cultures were found to possess 
relatively high levels of the enzyme, while many of the Lpa cells 
tested did not possess detectable amounts of the activator in 
their serum-free culture media. The results presented in table 1 
establish a correlation between the observed frequency of positive 
colonies in a casein plasminogen overlay assay and the amount of 
enzyme present in serum-free cell culture fluids. These results 
also validate the use of the casein plasminogen overlay technique 
as an efficient method for isolating populations of cells which 
produce and/or release different amounts of PA. It is presumed that 
the amounts of plasminogen activator detected in supernatant fluids 
also reflect the amounts of activator present under normal growth 
conditions. Calf serum is known to contain inhibitors of plasmin 
and this has prevented the detection of plasminogen activation in 
the normal growth media [5]. 
It is unlikely that the low levels of PA as found in Lpa cell 
culture fluids were entirely due to the presence of a cell associated 
or soluble inhibitors. This conclusion is supported by a number of 
observations. A short incubation (10 min.) of Hpa culture fluid 
with monolayers of Lpa cells did not result in a loss of activator as 
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measured by l25I -fibrin release. In another experimental approach, 
equal numbers of Hpa and Lpa cells were mixed and the amounts of 
activator present in serum-free culture fluids were determined. In 
the experiment reported in table 2, the amount of activator was 
determined after one serial passage of the cell mixture. The fre-
quencies of cells yielding activator positive colonies represent 
those of various cell populations at the time at which serum-free 
supernates were prepared. The fluids from the co-cultivated cells 
contained detectable amounts of the enzyme and the frequency of 
activator positive colonies which arose from the population suggests 
that Lpa cells were present. The decrease of activator in mixed cell 
culture fluid correlates with that expected from the decrease in 
positive colonies. 
Table 2. Frequencies of activator positive colonies and levels of 





Hpa-6 x Lpa-6 





Reciprocal of greatest 
dilution of supernate 




It is possible that differences in extracellular PA result from 
different levels of PA production. To test this, intracellular 
extracts of Hpa-l and Lpa-4 cells were obtained by treating confluent 
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cell monolayers with Q.5% V/V Triton X 100 as described previously 
by Unkeless et al. ll2J. As shown in table 3 PA was not detectable 
in extracts from Lpa-4 cells. It should also be noted that treatment 
of BHK-2l/C13 cells with Triton X 100 failed to release PA and that 
they also fail to produce detectable amounts of extracellular activa-
tor. These results suggest that differences in extracellular PA can 
be accounted for by differences in activator production. However, 
intracellular determinations were not made for all Lpa isolates and 
it is also possible that some Lpa populations may produce high levels 
of PA but release relatively small amounts of the activator. 















a. One unit of PA correspond~to the amount of activator necessary 
for release of 5% of the 125I-fibrin. 
b. Protein determinations were performed according to Lowry et al. 
(1951). 
Efficiencies of Plating and Growth 
in Agar Suspension 
In examining various cell isolates, no apparent correlation 
between the amounts of plasminogen activator and efficiencies of 
plating on Falcon Petri dishes or abilities to grow in soft agar 
Table 4. Plasminogen activator production and efficiencies of plating in soft agar and on 
plastic surfaces. 
Frequency Reciprocal of 
of greatest dilution 
activator of supernate Cells forming Efficiency of 
Cell positive yielding visible colonies in plating on 
isolate colonies clot lysis soft agar plastic surfaces 
BHK-2l/N 0.224 1 54.5 ± 3.5% 69.5 ± 4.0% 
Hpa-l 1.000 32 50.8 ± 9.3% 81.5 ± 9.0% 
Hpa-2 1.000 32 53.0 ± 7.8% 66.0 ± 3.3% 
Hpa-3 1.000 32 58.0 ± 5.0% 91.0 ± 3.6% 
Hpa-4 1.000 32 58.5 ± 4.9% 82.5 ± 3.5% 
Lpa-l 0.159 No Lysis 73.8 ± 6.9% 67.0 ± 3.9% 
Lpa-2 0.202 1 65.0 ± 6.7% 65.0±15.0% 
Lpa-3 0.032 ND 50.5 ± 4.8% 62.0 ± 3.9% 
a. The values expressed for efficiencies of plating represent the mean with 95% 
confidence limits. 




suspension were found. As shown in table 4, BHK-2l/N and isolates 
derived from them shared similar growth properties. These cells all 
possessed high efficiencies of plating on plastic surfaces and 
abilities to grow in soft agar. These characteristics were judged 
to be independent of the amounts of plasminogen activator produced. 
For example, Lpa-l had the highest efficiency of plating in soft agar, 
while Lpa-2 and Hpa-l shared the lowest efficiencies of plating in 
soft agar. Likewise, the efficiency of plating of Hpa-2 cells on 
plastic surfaces was similar to that observed with Lpa isolates. 
Growth Rates 
Growth rates were determined for a number of Hpa and Lpa iso-
lates and these results are depicted in figure 1 and table 5. There 
was no apparent correlation between activator production (table 1) 
and the respective growth rates of those cells examined. However, 
the growth rates for Lpa-4, Lpa-5 and Hpa-l were determined at 
different time periods in the investigation than those for Lpa-6 and 
Hpa-6 cells. In comparing those growth rates determined at the same 
time, the Lpa cells demonstrated faster growth than their Hpa counter-
parts. This finding is consistent with the observation that Lpa 
colonies were larger than Hpa colonies when plated under identical 
conditions. It must also be noted that Lpa cells were initially 
selected as larger colonies. Aside from these considerations, it is 
apparent that those cells capable of releasing and/or producing 
increased levels of plasminogen activator do not possess increased 
growth rates. 
Fig 1. Abscissa: Time in hours; Ordinate cell number XlO-5 • 
Growth of Hpa and Lpa isolates. Lpa-4 (e __ e __ e), Lpa-5 
(0-0-0), Lpa-6 ( D -- D -- D ), Hpa-l ( I --- D - D ), and 
Hpa-6 (~--~--~) cells were grown in MEM + 5% CS, the points 
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Table 5. Generation times of Hpa and Lpa isolates. 
Cell isolate Estimated (a) generation time 
Lpa-4 13.2 hr 
Lpa-5 16.9 hr 
Hpa-l 17.6 hr 
Lpa-6 12.6 hr 
Hpa-6 15.5 hr 
a. The generation times were estimated from the slopes of the 
curves depicted in fig 1. 
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A further argument against a relationship between extracellular 
activator and cell growth stems from the observation that the 
frequencies of activator positive colonies remained rather stable 
during the serial passage of a number of isolates and examples of 
this are shown in table 6. If the action of plasminogen activator 
did affect cell growth rate this should result in a selection for 
either an increase or decrease in the frequency of activator 
positive colonies during the serial passage of cells. This did not 
occur and is interpreted as further evidence against any relationship 
between the levels of extracellular enzyme and cell growth rate. 
To further test this point, cell co-cultivation was employed. 
Equal numbers of Hpa and Lpa cells were mixed and the frequen-
cies of activator positive colonies were determined at various times 
during their serial passage. The results of this experiment are 
shown in table 7. The frequencies of activator positive colonies 
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Table 6. Frequencies of activator positive colonies during extended 
periods of serial cell passage. 
Number of 
positive 
colonies per Frequency 
Cell Passage total colony positive 
isolate level number colonies 
BHK-2l/N 6 102/719 0.142 
BHK-2l/N 25 152/1323 0.115 
BHK-21/N 39 210/938 0.224 
Hpa-l 5 1462/1462 1.000 
Hpa-l 16 1056/1056 1.000 
Hpa-l 27 1017/1024 0.993 
Lpa-4 1 8/1245 0.006 
Lpa-4 11 10/1440 0.007 
Lpa-6 1 7/710 0.01 
Lpa-6 8 11/1085 0.010 
a. Passage levels for BHK-21/N represent the number of serial 
passes since the initiation of these studies. 
b. Passage levels for Hpa and Lpa isolates represent the 
numbers of serial passes since the time of their isolation. 
of 
Table 7. Co-cultivation of Hpa and Lpa cells. 
Frequency of activator positive colonies ( Positive Colonies ) 
(Total Colony Number ) 
Passage level 
Cell isolate 1 2 3 5 8 
0.987 480 0.913 304 1.00 70 1.000 195 0.891 291 486 333 70 195 327 Hpa-6 
0.456 308 0.355 309 0.20 20 0.08 43 0.008 7 675 871 98 562 883 Hpa-6 x Lpa-6 
Lpa-6 0.01 0.009 0.06 15 ND 0.010 11 710 667 250 1085 




decreased during serial passage. A similar finding was also obtained 
when Lpa-4 and Lpa-5 cells were mixed with Hpa-l cells and the 
frequency of activator positive colonies determined after 11 serial 
passages. Growth rates for the cells employed in co-cultivation were 
given in table 5. The observed decrease in activator positive 
colonies is reasonably attributed to the higher growth rates of the 
Lpa cells. These findings support the postulate that cells capable 
of releasing increased extracellular plasminogen activator do not 
exhibit enhanced cell growth under the conditions utilized for cell 
propagation. 
DISCUSSION 
The use of plasminogen casein overlays provides a rapid and 
effective means of cloning cells which release different amounts of 
plasminogen activator into serum-free media. The differences in 
activator production can be observed by determining either the 
frequencies of activator positive colonies arising from various 
cell populations or by measuring the amount of activator in serum-
free culture fluids. Cells isolated from BHK-2l/N exhibited 
relatively large differences in amounts of extracellular plasminogen 
activator. 
Further characterization of these cells revealed a lack of 
correlation between amounts of extracellular PA and their growth 
rates or efficiencies of plating in soft agar or on plastic surface. 
Such findings are not supportive of previous conclusions of Pollack 
et al. [6] and Taylor 15]. However, Wolf and Goldberg I13] have 
53 
recently reported a lack of correlation between either the growth of 
RSV transformed chick cells in soft agar or their rate of glucose 
transport and the levels of extracellular activator in cell culture 
fluids. Jones, Laug and Benedict 114] were also unable to find a 
relationship between either growth in suspension, saturation 
densities, or tumorigenicity, and levels of extracellular activator 
in cultures of human fibrosarcoma cells. Reasons for such apparent 
contradictions are unclear. Yet, such findings rule out any general-
ization concerning the relationships of plasminogen activator to 
the growth of cells suspended in semi-solid media. 
It is presumed that the amounts of activator which are present 
in serum-free supernates reflect the amounts of activator present in 
normal growth media. With the methods employed to assay PA this 
could not be confirmed due to the presence of large amounts of 
plasmin inhibitors in normal calf serum I5J. Nonetheless, it is 
concluded that cells which have relatively large amounts of activator 
in their serum-free culture media do not possess any enhanced growth 
properties under the conditions employed for cell propagation. This 
conclusion stems from a number of experimental observations. As 
shown in table 6, the frequency of activator-producing colonies 
remained stable during extended cell passage. Fig 1 and table 5 
show that the growth rates of Hpa cells were not consistently 
greater than those of Lpa cells. Further supportive evidence came 
from the cell mixing experiment. When Hpa cells were co-cultivated 
and then followed during serial passage, a decrease in the number 
of activator positive colonies was observed. This is in direct 
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contrast to what would be expected if the presence of extracellular 
enzyme did favor cell growth. 
Work of Mott et ale 115], Goldberg [9J, and also unpublished 
data from this laboratory confirm that plasminogen activator produc-
tion is not a unique quality of transformed cells. Many normal 
cells including primary fibroblasts have been shown to produce the 
enzyme. Although large differences in amounts of extracellular 
activator may be observed in culture fluids of various cells, it 
is plausible to suggest that all cells produce enough plasminogen 
activator to provide a required physiological function. However, 
it is unclear whether extracellular levels of the enzyme are in fact 
physiologically important. It is possible that the enzyme may func-
tion intracellularly or while membrane associated. 
With the exception of chick cell plasminogen activator [12], 
little is known about the specific action of activators found in 
cell culture fluids on plasminogen. Furthermore, protein substrates 
other than plasminogen have not been reported and attempts to 
identify susceptible surface components have been unsuccessful [16, 
l7,J. It is also possible that cells release a number of molecules 
with activator activity. Poste [18J has shown that more than one 
species of activator can be separated from SVT2 culture fluids by 
exclusion chromatography while Christman, Silverstein and Acs ll9J 
have reported that different cells from the same animal species are 
capable of releasing antigenically distinguishable activators. 
The specificity of the activator released by BHK-2l/N cells 
and its intracellular localization is currently being investigated. 
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The elucidation of such properties for the activator produced by 
BHK-21/N as well as other cell lines may well preclude the discovery 
of its physiological function and importance in cell transformation. 
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CHAPTER III 
BIOCHEMICAL PROPERTIES OF A PLASMINOGEN 
ACTIVATOR FROM BHK CELLS 
by 
Robert W. Snyder and Douglas W. Hill 
59 
SUMMARY 
A plasminogen activator which was produced by a high passage 
hamster kidney cell line (Hpa-6) was characterized biochemically. 
The enzyme was found to be inhibited by diisopropylfluorophosphate 
and therefore was considered to be a serine protease. Hpa-6 cell 
activator was also found to react with plasminogen in a manner which 
was indistinguishable from the action of urokinase on the proenzyme. 
Evidence was obtained which suggests that the activator can hydro-
lyze either of the two molecular forms of plasminogen, i.e., 
plasminogen with glutamic acid amino terminus or plasminogen with 
lysine amino terminus at a single position to yield active plasmin. 
The cellular localization of the Hpa-6 cell plasminogen activator 
was examined and the results obtained indicate that this activity 
was largely associated with the plasma membrane. 
INTRODUCTION 
A large number of cell types grown in vitro have been shown 
to release enzymes which are capable of activating plasminogen 
Il,2,3,4,5,6,7,8,9]. This phenomena has generated much interest 
since investigators had previously suggested that the action of 
proteolytic enzymes may be involved in alteration of the in 
---
phenotypic properties of cells flO,llJ. There have been a number 
of reports which have attempted to relate the presence of amounts 
of extracellular activator with alterations of cellular phenotypic 
properties 12,8,12,13,14,15J and generally their conclusions have 
not been in agreement. 
Some of the confusion which has resulted from these studies may 
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be ascribed to the use of a variety of cell lines which may produce 
activators with different enzymatic capabilities and/or biological 
functions. Cells from different species and similar cells obtained 
from the same species have been shown to release activator molecules 
which differ in molecular weight [6,16,17J or are antigenically 
unrelated [18,19J. Unkeless et ale [17J and Christman et al. [20] 
have also provided evidence that the cellular localization of plas-
minogen activator differs in chick cells transformed by Rous sarcoma 
virus versus hamster cells transformed by SV40 virus. 
Since researchers will continue to employ a variety of cells to 
investigate the possible effects of extracellular proteases on cell 
growth or behavior it is of obvious importance that those proteoly-
tic enzymes dealt with be examined and described. In this regard, 
biochemical information would not only be useful toward elucidating 
the biological functions of such enzymes but would allow for more 
accurate comparisons of results obtained with different cell lines. 
In our previous studies cells which differed in the amount of 
extracellular plasminogen activator were cloned from a high passage 
hamster cell line which had originated from BHK-2l/C13 [21], and 
populations of these cloned cells designated Hpa (possessing high 
levels of extracellular activator) and Lpa (possessing low levels 
of extracellular activator) were examined with regard to a number of 
growth properties. This report is directed toward presenting data 
concerning some of the biochemical and enzymatic properties of the 
activator released by Hpa cells. More specifically, the following 
results will provide information concerning the action of this enzyme 
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on plasminogen, the effects of various inhibitors on its activity, and 
the intracellular localization of this protease. 
MATERIALS AND METHODS 
The cells used in these studies (Hpa-6) were selected for their 
ability to release large amounts of plasminogen activator [21). 
These cells were isolated from BKH-21/N cells which had been serially 
passaged at least 200 times in culture and that had originated from 
BHK-21/C13 cells. The Hpa-6 cells were grown in Eagle's medium (MEM) 
(Gibco) supplemented with 5% calf serum (CS) (Flow Labs). 
Concentration of Extracellular 
Plasminogen Activator 
Hpa-6 cells were seeded into Corning plastic roller bottles and 
incubated at 37°C until the cells were nearly confluent. The MEM 
with 5% CS was removed and cells were gently washed with three changes 
of phosphate buffered saline without added calcium and magnesium ions 
(PD). A 50 ml volume of MEM without calf serum was added to each 
bottle and the cells were incubated for approximately 18 hours at 
37°C. The serum-free supernates to be used for activator concentra-
tion were then removed and MEM with 5% CS was added back to the 
roller bottles. This entire procedure was repeated once more after 
the cells had been incubated for 5 additional hours in the presence 
of normal growth medium. The method employed for plasminogen activa-
tor concentration was essentially that of Christman and Acs [16). 
The ser~free culture fluids were centrifuged for 10 minutes at 
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~OOO g in a refrigerated centrifuge immediately following their har-
vest. Supernates were carefully removed and the pellet containing 
cellular debris was discarded. These fluids were then filtered 
through Whatman #50 filter paper and adjusted to pH 3.0 by the addi-
tion of LM HCl. The acidic solution was placed in an ice bath and 
brought to 50% saturation by the addition of solid ammonium sulfate. 
Following 30 minutes at 4°C, this solution was centrifuged for 15 
minutes at 7,000 g in a refrigerated centrifuge. The pellet was 
resuspended in 0.0125 times the original volume with a 0.05M glycine 
buffer at pH 3.0. This preparation (stage 1) was frozen at -70°C. 
The entire procedure was repeated for the second batch of culture 
fluids and the stage 1 fractions from both harvests were pooled, and 
a precipitate was removed following its centrifugation at 11,000 g 
at 4°C for 15 minutes. The resulting supernate (stage II) was 
dialyzed twice against 100 volumes of O.005M phosphate buffer at 
pH 7.4 and aliquots of the dialysate (stage III fluid) were then 
frozen at -70°C. Protein determinations of crude harvest fluids and 
stage II fractions were performed according to Lowry et ale [22]. 
Radioactive Labeling of Plasminogen 
Plasminogen was purified according to the method of Deutch and 
Mertz [23] and it was then reacted with [3H] acetic anhydride (2Ci/m 
mole) (New England Nuclear) as described by Montelaro and Reuckert 
[24]. The amount of [3H] acetic anhydride added was in 5 molar ex-
cess of the amount of plasminogen present. 
Alternately, the plasminogen was labeled with l25Iodine. In this 
63 
case, the plasminogen used for iodination was first rendered free of 
most residual plasmin by adding a plasminogen solution to Affigel-IO 
beads (Bio Rad) to which soy bean trypsin inhibitor had been pre-
viously coupled. Following a 60 minute incubation at 4°C, the gel 
beads were removed by low speed centrifugation. The resulting plas-
minogen solution was iodinated by the method of Helmkamp et ale 
[2S] and l2S1 and iodine chloride (ICI) were added to give a ratio 
of approximately 3 moles ICI to 1 mole plasminogen. Both [3H] acetic 
anhydride and l2S1 labeled plasminogen were then freed of non-
reacted radioactivity by column chromatography with Bio Rad PIO 
equilibrated with O.OOSM phosphate buffer at pH 7.4 and appropriate 
aliquots of radiolabeled plasminogen were frozen at -70°C. 
Activation of Radioactive Plasminogen 
All reactions were carried out in a final concentration of 
approximately 0.1M Tris buffer at pH 8.1 or 8.S. Appropriate volumes 
of stage III activator were added to aliquots of radiolabeled plasmin-
ogen and incubated at 37°C. The volumes of each reactant varied 
in different experiments and are indicated in the text. The reac-
tions were stopped at desired times by the addition of equal volumes 
of 10% glycerol, S% S-mercapto-ethanol, 3% sodium dodecyl sulfate 
(SDS) and 0.062SM Tris at pH 6.8 (sample buffer used for SDS poly-
acrylamide gel electrophoresis) followed by immediate freezing at 
-20°C. 
SDS Polyacrylamide Gel Electrophoretic 
Analysis of Radiolabeled Proteins 
The electrophoresis of plasminogen or activated plasminogen 
64 
preparations were carried out in the presence of SDS as previously de~ 
scribed by O'Farrel et al. [26]. The plasminogen plus activator reaction 
mixtures which were in sample buffer were thawed immediately by 
placing them in a boiling water bath for approximately 2 minutes and 
appropriate sample volumes were then electrophoresed. Gels which 
contained 3H labeled plasminogen were prepared for fluorography [27] 
and RPX o-mat X-ray film was employed to locate and identify plas-
minogen or split products derived from the proenzyme plasminogen. 
Gels which contained l25I-plasminogen were simply fixed with 12% 
acetic acid, dried under vacuum, and used to expose the X-ray film. 
These resultant autoradiographs were placed above the original gel 
and the appropriate regions were identified and cut from the gels and 
radioactivity was assayed in a Beckman Biogamma counter. 
Fluorescamine Labeling and Isolation of Plasma 
Membrane Enriched Fractions 
The preparation of plasma membrane enriched fractions was 
accomplished by use of a method similar to that reported by Atkinson 
and Summers [28]. Hpa-6 cells were grown in 15 rom Lux Petri dishes 
to approximately 50% confluence, washed twice with 15 ml volumes of 
PD, and 5 ml volumes of PD were added. One-half of these cell cul-
tures were reacted with fluorescamine by adding 0.02 ml volumes of 
10 mg/ml Fluoram (Roche Diagnostics) in acetone. The PD and PD plus 
hydrolyzed fluorescamine were removed, cells were washed twice more 
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with 15 ml volumes of PD, and 5 ml volumes of 0.005M EDTA plus 
1 mg/ml bovine serum albumin in PD were added. Following 5 minutes 
at room temperature the loosely adherent cells were removed by 
pipetting the fluid from each dish onto patches of the monolayer. 
The suspensions of cells were pooled and placed in 12 ml conical 
centrifuge tubes and pelleted by low speed centrifugation. The 
cells were washed in PD, repelleted, and suspended in a volume of 
swelling buffer (O.OIM Tris plus 0.1 roM MgC12 at pH 7.4) which was 
at least 20 times greater than that of the cell pellet. Following 
4 or 5 minutes in an ice bath, the cells were ruptured with a stain-
less steel Dounce homogenizer (0.002 inch clearance). The cell 
homogenate was brought to 3mM MgC12 and O.OIM NaCl and then centri-
fuged to remove whole cells and nuclei. The resulting supernate was 
held on ice and appropriate volumes were added to the top of a 
discontinuous sucrose gradient which contained 3.3 ml 50%, 3.3 m1 
39%, and 3.3 ml 20% sucrose in ET buffer (O.1M Tris and 0.001 M 
EDTA at pH 7.4). These gradients were centrifuged in a Beckman 
SW41 rotor at 37,000 rpm for 3 hours at 4°C. Fractions (0.55 ml) 
from the gradient were collected and aliquots of each frozen. 
Determination of Plasminogen 
Activator Activity 
Two methods were employed to quantitate amounts of plasminogen 
activator. An l25I-fibrin release assay was performed in a manner 
similar to that described by Unkeless et ale [3) with the following 
modifications: (1) l25I -fibrin was clotted by addition of 0.1 u/ml 
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bovine thrombin (Parke-Davis) in the presence of phosphate buffered 
saline for 2 hours at 37°C; (2) the assays were carried out in Costar 
multiwelled dishes (16 mm) with 0.1 ml of plasminogen (approximately 
0.1 mg/ml), 0.1 ml of 0.1M Tris (pH 8.1) and 0.1 ml of activator 
preparation in each well. The plasminogen had been purified from 
outdated human plasma by the method of Deutch and Mertz [23]. 
Plasminogen activator was also assayed by use of casein-plasmin-
ogen containing overlays. Petri dishes were filled to a depth of 
2-3 rom with 0.4% agarase, 0.4% denatured skim milk and 0.01 mg/ml 
plasminogen in PD. Wells of approximately 4 rom in diameter were cut 
out and filled with 0.02 ml of an activator preparation. The diame-
ter of the zone of clearing was measured after the plates had been 
incubated at 37°C for 24 hours. The log of activator concentration 
was plotted versus the log of the diameter of visible lysis to yield 
a standard line. 
RESULTS 
Table 8 shows a typical preparation of the stage III Hpa-6 cell 
activator contained approximately 92% of the original activity in 
about 0.0125 times the original volume. The mechanism of activation 
of l25I-labeled plasminogen by stage III Hpa-6 cell activator and 
urokinase (Cal-Biochem) was examined. An autoradiograph of the 
l25I-labeled plasminogen which had been reduced in S-mercaptoethanol 
and electrophoresed in an SDS polyacrylamide gel is shown in fig 2b. 
This particular preparation appears relatively free of other 
Table 8. Concentration of activator from Hpa-6 cell culture field. 
Volume Protein 
Stage I 700 ml 2.1 mg 
Stage III 8.6 ml 0.8 mg 
Activatora 
5.6 x 104U 
5.16 x 104U 
Specific 
Activity 
2.66 x 104 uimg 




~. Units of activator are relative to the amount present in a standard pool of cell 
culture fluid and 0.6U of activator results in the release of approximately 
5% of the 1251 fibrin in the assay system employed. 




contaminating proteins and the only visible bands corresponded to the 
two molecular forms of plasminogen. It should be noted that the 
smaller peptide corresponding to the plasmin light chain is not 
visible and the amount of radioactivity at this position was at least 
100 times less than the amount present in the plasminogen bands. In 
figs 2c and 2d the products resulting from the proteolytic activation 
of l25I-labeled plasminogen by Hpa-6 cell activator and urokinase 
respecitvely are shown. These products were compared to 35 S_ 
methionine-labeled T4 phage marker proteins supplied kindly by G. 
Stetler and shown in fig 2a. The apparent molecular weights for Glu-
PIn (plasminogen with flutamic acid at the amino terminal position), 
Lys-Pln (plasminogen with lysine at the amino terminal end), Glu-H 
(heavy plasmin chain derived from Glu-Pln), and Lys-H (heavy plasmin 
chain derived from Lys-Pln) are larger than those commonly reported 
[29,30,31,32] but were comparable to those depicted by Dano and Reich 
[33] who employed a similar electrophoresis system. It should be 
pointed out that the use of the designations Gly-Pln and Lys-Pln for 
the two moledular forms of plasminogen was based on data communicated 
by other authors who had examined the terminal amino groups of puri-
fied human plasminogen I34,35]. As seen in figs 2c and 2d the prod-
ucts resulting from plasminogen activation by urokinase or Hpa-6 cell 
activator appear to be indistinguishable. Both molecular forms of 
plasminogen (Glu-Pln and Lys-Pln) were activated. This conclusion is 
based on the presence of a single plasmin light chain (PI) and two 
distinguishable plasmin heavy chains (Glu-H and Lys-H) which have an 
apparent molecular weight difference which was consistent with that 
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Fig 2. Polacrylamide SDS gel electrophoresis of 1251 plasmino-
gen and activation products. All reaction mixtures were incubated 
for 1 hour at 37°C, diluted 2-fold in sample buffer and reduced by 
boiling, and appropriate samples were run in the wells corresponding 
to the following reaction mixtures: b: 20 ~1 l2SI plasminogen 
(z20~gm) + 5~1 0.4M Tris (pH 8.S) + 20~1 O.SmM sodium phosphate 
(pH 7.4) + 5~1 H20. c; 40~1 l2SI plasminogen (z40~gm) + 10~1 0.4M 
Tris (pH 8.S) + 40~1 stage III activator + 10~1 Traysylol (10,000 
u/ml). d; 20~1 l2SI plasminogen (z20~gm) + 5~1 0.4M Tris (pH 8.S) 
+ 20~1 urokinase (35u/ml) + S~l Traysy10l (lO,OOOu/ml). e; 20~1 
1251 plasminogen (z20~gm) + 5111 0.4M Tris (pH 8.5) + 20111 streptokinase 
(l,OOOu/ml) + 5~1 H20. f; 20~1 1251 plasminogen (~20lJgm) + S1-11 
0.4M Tris (pH 8.S) + 20lll urokinase (3SlJlm1) + S1-1l H20. The proteins 
in well a are from 3SS-methionine-labeled T4 phage and their estimated 
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expected if the heavy plasmin chains were derived from the amino ter-
minal portions of Glu-Pln and Lys-Pln. The activation of Gly-Pln 
Lys-Pln by Hpa-6 cell enzyme seemed to be equally as efficient. In 
this regard, the regions of the gel corresponding to each form of 
the zymogen and each of heavy plasmin chains were cut out of some 
gels in which they were well separated and the ratio of radioactivity 
of Glu-Pln/Lys-Pln was compared to Glu-H/Lys-H. These ratios 
(Glu-Pln/Lys-Pln=0.684 and Glu-H/Lys-H = 0.686) were found to be 
nearly identical as would be expected if both forms were cleaved at 
the same rate. 
The activation of plasminogen was examined as a function of time 
and activator concentration. In fig 3 the amounts of radioactivity 
in the positions corresponding to plasmin light and heavy chains in-
creased with time when l25I-plasminogen was reacted with a constant 
amount of Hpa-6 cell activator. When 3H plasminogen + Hpa-6 cell 
activator reaction mixtures were electrophoresed and fluorographed 
the amount of plasmin light chain (see fig 4) was found to be depen-
dent upon the concentration of activator added. 
The effects of some inhibitors on Hpa-6 cell activator were also 
examined. As shown in fig 5 a 1 roM concentration of diisopropyl-
fluorophosphate (DFP) was very effective in inhibiting the enzyme. 
The amount of plasmin light chain present in the DFP containing reac-
tion mixture was determined by cutting the corresponding band out of 
the gel and determining radioactivity. The radioactivity in this 
plasm band was only 20% of the amount obtained from a control reac-
tion mixture which contained 3% propanol and 1 roM toysyllysylchloro-
Fig 3_ Abscissa: Time in minutes; ordinate (left) % of 
radioactivity in plasmin heavy chains versus total radioactivity 
in all bands (.------) (right) % of radioactivity in plasmin ·light 
chain versus total radioactivity in all bands (.-.-.). 
Kinetics of plasminogen activation by Hpa-6 cell activator_ 
The following reaction mixture was incubated at 37°C, aliquots were 
removed at appropriate times and diluted 2-fold with gel electro-
phoresis sample buffer, reduced by boiling, and electrophoresed. 
Appropriate bands were cut from the gels and the radioactivity 
determined. Reaction mixture: l80~1 1251 plasminogen (~18~gm) 
+ l80~1 Hpa-6 cell stage III activator + 45~1 0.4M Tris at pH 8.5 
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methylketone (TLCK). This decrease in the activity of Hpa-6 cell 
activator resulted from a 30 minute pre-incubation of the enzyme 
with DFP. Though the kinetics of inactivation by DFP were not 
examined, the data which were obtained strongly suggest that the 
activator is a serine protease [36]. A 1 roM concentration of 
tosylphenylchloromethylketone (TPCK) was without effect on the 
enzyme. In further studies which employed 3H plasminogen as sub-
strate a decrease in activator activity was noted in the presence 
of tosylarginylmethyl ester (TAME). This finding was based on the 
visualization of decreased amounts of plasmin light chain in fluor-
ographed reaction mixtures (fig 6) which contained 0.5 roM TAME or 
0.05 roM TAME. However, this decrease in amount of plasmin light 
chain was not quantitated. 
Plasminogen activator from Triton X 100 extracts of Hpa cells 
has been obtained and further studies were performed to identify 
74 
its cellular localization. As described in the methods section, 
cell surface molecules were labeled with fluorescamine, fractions 
enriched for plasma membrane were prepared, and the material was 
centrifuged to equilibrium in sucrose gradients. Fig 7 shows the 
results of this analysis. Fractions 12, 13, and 14, which contained 
approximately 50% of the detectable activity, were the only frac-
tions which possessed visible fluorescence and contained fluorescent 
plasma membrane ghosts as determined by microscopy. This strongly 
suggests that much of the cellular activator may be associated with 
the plasma membrane. It should also be noted that greater than 50% 
of the enzymatic activity which was added to the gradient could be 
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Fig 4. Polyacrylamide SDS gel electrophoresis of 3H plasminogen 
activated by various concentrations of stage III Hpa-6 cell activa-
tor. The reaction mixtures contained TLCK as an inhibitor of plas-
min and they were incubated at 37°C for one hour before addition of 
electrophoresis sample buffer. All reaction mixtures contained 20~1 
3H plasminogen (~lO~gm), 5~1 O.35M Tris (pH 8.5) with O.07M TLCK, 
and a through e also contained the following: a· , 25~1 5 roM sodium 
phosphate (pH 7.4). b; 20~1 5 mM sodium phosphate (pH 7.4) + 5~1 
stage III activator. c; 15111 5mM sodium phosphate (pH 7.4) + lO~l 
stage III activator. d-, lO~l 5mM socium phosphate (pH 7.4) + l5~1 
stage III activator. e· , 25~1 stage III activator. 
G I u - Pin 
L'ys -Pin 
PI ~-
ab c d e 
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Fig 5. Polyacrylamide SDS gel electrophor~sis of plasminogen 
activated by DFP treated stage III activator. The reaction mixtures 
represented in a and b each contained 2~1 1251 plasminogen (~2~gm), 
l6~1 stage III activator, and l5~1 0.35M Tris (pH 8.5) with 3.5 mm 
TLCK and were incubated at 37°C for 1 hour prior to the addition 
of electrophoresis sample buffer. The stage III activator in well 
a had been pre-incubated for 30 minutes at 25°C with a final concen-
tration of 1 roM DFP and 3% propanol, the stage III activator in 
well b was pre-incubated for 30 minutes at 25°C with a final con-
centration of 3% propanol. 
Glu-Pln • 
Lys-Pln ., 
P I • 
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accounted for. 
The apparent activity of plasminogen activator could be enhanced 
when Triton X 100 was added to the 1251 fibrin release assay reaction 
mixture. In view of the plasma membrane association of Hpa-6 cell 
activator it seemed possible that some of the cell culture fluid 
activity could still be associated with plasma membrane vesicles or 
fragments and that this association could account for the enhance-
ment by Triton X 100. It was found that when 0.166% Triton X 100 
was present in the l25 I-fibrin assay the amount of 1251 fibrin re-
leased by Hpa-6 cell activator plus plasminogen was nearly doubled. 
However, when streptokinase (a presumably soluble activator of 
bacterial origin) and plasminogen were preincubated and then assayed 
by l25I-fibrin release a similar enhancement of fibrin release by 
added Triton X 100 was observed and Triton X 100 also increased the 
amount of l25I-fibrin solubilized in control reactions which did 
not contain activator and/or plasminogen. Since the l25I-fibrin 
which serves as substrate in these assays was first insolubilized 
on the surface of Petri dishes it is possible that the detergent 
(Triton X 100) could increase the solubility of 1251 fibrin substrate 
or l25I-fibrin degradation products and thereby raise the total 
1251 released. 
A second approach was then employed to investigate whether the 
activator present in cell culture fluids could be associated with 
membranous material. Serumrfree Hpa-6 cell culture fluids were ob-
tained after 18 hours of incubation. The harvested fluids were 
Fig 6. Polyacrylamide SDS gel electrophoresis of 3H plasmino-
gen activated by stage III activator in the presence of TAME. 
The reaction mixtures contained TLCK as an inhibitor of plasmin 
and were incubated at 37°C for three hours before the addition of 
electrophoresis sample buffer. They all contained 15~1 3H plasmin-
ogen (~7.5pgm), IO~1 O.45M Tris (pH 8.2) with O.045M TLCK, and 
20~1 stage III activator. Additionally, mixture b contained l~l 









Fig 7_ Abscissa: Fraction number from gradient; Ordinate (left) 
units of plasminogen activator activity, (right) density of sucrose 
gm/cm3 (-----); top: visible fluorescence (+). 
Sucrose gradient fractionation of Hpa-6 cellular material. 
Aliquots from each fraction were diluted 2-fold in 0.5% Triton X 100 
and the amount of activator in a 20~1 volume was measured by means 
of casein and plasminogen containing overlays as described in 
Materials and Methods. The units of activator activity were deter-
mined relative to a standard cell culture fluid and are the same 
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centrifuged twice at low speed in conical tubes to remove any whole 
cells or large debris and Triton X 100 was added to some of the 
aliquots to yield a final concentration of 0.5%. Samples with and 
without the Triton X 100 were centrifuged at 100,000 g for one hour 
at 4°C and the supernates and sedimented material were carefully 
obtained. All preparations were brought to 0.5% Triton X 100 and 
assayed for l25I-fibrin release. As shown in table 9, 31% 
of the supernate activity was pelleted in the absence of Triton X 
100, while only 3% of the activity was sedimented in the presence 
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of 0.5% Triton X 100. The evidence suggests that some of the acti-
vator is particulate and possibly associated with membranous material. 
However, this is not conclusive and further experiments have not 
been performed. 
DISCUSSION 
The results presented (see fig 2) show that the products result-
ing from the activation of plasminogen by Hpa-6 cell activator or 
urokinase were indistinguishable. Early reports had suggested that 
a preactivation peptide was first removed from Glu-Pln to yield 
Lys-Pln [37,38,39] and the subsequent activation of Lys-Pln was 
accomplished by the hydrolysis of a single arginyl-valine bond in 
the Lys-Pln proenzyme [39]. However, the experiments which led to 
these conclusions were difficult to interpret in that it was also 
possible that the autoproteolytic action of plasmin could have 
accounted for the conversion of Glu-Pln to Lys-Pln. Recently, 
investigators have employed the proteolytic inhibitor Traysylol to 
Table 9. High speed centrifugation of cell culture fluids with and without 
Triton X 100 
Activator Activity (c) 
Preparation in Units % of Total 
100,000 G supernatant 210 69 
100,000 G pellet 96 31 
100,000 G Triton X 100 supernatant 317 93 
100,000 G Triton X 100 pellet 11 3 
a. Plasminogen activator was measured by 1251 fibrin release and units are 
as defined in Table 8. 
00 
l/l 
examine plasminogen activation and found that the cleavage of the 
preactivation peptide did not occur when plasmin was inhibited [40] 
and the results reported here confirm these findings. Evidence was 
presented which suggests that Hpa-6 cell activator and urokinase 
can activate either the Glu-Pln or Lys-Pln form of the zymogen 
through the splitting of a single peptide bond. Further evidence 
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was also presented that suggests that the Hpa-6 cell activator reacts 
with Glu-Pln or Lys-Pln with equal efficiency. Our findings are 
different from those reported by Unkeless et ale [17] following 
their investigation of the activation of plasminogen with the acti-
vator from RSV transformed chick cells in the presence of Traysylol. 
These authors had concluded that the rate of activation of Lys-Pln 
by chick cell activator was greater than the conversion of Glu-Pln. 
It is possible that the reaction mixtures which they examined con-
tained active plasmin. The presence of plasmin in their reaction 
mixtures was evidenced by the presence of "large degradation material" 
which migrated slightly further than Lys-H in their electrophoretic 
system and which was clearly distinguishable in the autoradiographs 
presented. These "large degradation peptides" were also noticed in 
the present studies in autoradiographs (fig 2e and 2f) of those 
electrophoresed reaction mixtures which did not contain Traysylol 
or other suitable plasmin inhibitors. 
Aside from providing information on the mechanism of plasmin-
ogen activation by Hpa-6 cell activator our results also suggest 
that the Hpa-6 cell activator has a relatively specific action on 
plasminogen and may possess a rather narrow range of substrates. 
In this regard only one peptide bond in plasminogen was apparently 
cleaved by the activator. In contrast, plasmin's action on 
plasminogen (fig 2e and 2f) was found to result in not only the 
removal of the preactivation peptide but numerous other peptide 
fragments were observed. It should also be noted that crude cell 
culture fluids which contained plasminogen activator did not con-
tain any distinguishable proteolytic activity when 3H-hemoglobin 
or 3H- human serum albumin were employed as substrates and the re-
sulting reaction mixtures were electrophoresed and analyzed by 
fluorography (results not shown). Christman et ale [20] have re-
ported that the plasminogen activator released by hamster cells did 
not activate trypsinogen, chymotrypsinogen, or pepsinogen, while 
other investigators have been unable to demonstrate any loss of 
radiolabeled cell surface proteins when cells were incubated in 
the presence of fluids containing plasminogen activators [20,41]. 
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The effects of some inhibitors on the activity of Hpa-6 cell 
activator was also examined. A 1 mM concentration of TPCK was found 
to be without effect when added to a reaction mixture containing 
Hpa-6 cell activator. In contrast, a large reduction in activator 
activity was observed when it was incubated with 1 mM DFP for 30 
minutes. This result strongly suggests that the activator is a 
serine protease [36]. Similar conclusions have also been reported 
for activators released by Rous sarcoma virus transformed chick 
cells [17], cells obtained from human melanomas, [6] and SV40 trans-
formed hamster cells [16]. Unkeless et aL [17] have also reported 
that the chick cell activator was inhibited by TAME and similar 
findings were also observed for the Hpa-6 cell activator. 
Examination of the cellular localization of Hpa-6 cell 
activator has suggested that this activity may be associated with 
the plasma membrane. ,Hpa-6 cells were fluorescently labeled 
with fluorescamine a compound previously shown to react specifi-
cally with surface molecules [42]. When plasma membrane ghosts 
[28] which were prepared from the labeled Hpa-6 cells were centri-
fuged to equilibrium in sucrose gradients, much of the activator 
activity cosedimented with fluorescent membrane ghosts and all of 
the visible fluorescence (see fig 7). Since these materials co-
sedimented to a density (~1.16 gm/cm3) previously described as 
isopycnic for plasma membrane ghosts [28] it is likely that much of 
the plasminogen activator activity was associated with the cell 
membrane. 
Since the Hpa-6 cell plasminogen activator appears to be asso-
ciated with plasma membrane the presence of extracellular activator 
could reflect its active release from the cell surface, the budding 
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of membranous vesicles containing the activator, or membrane pertur-
bation and subsequent loss of surface material. Though these possi-
bilities have not been examined directly, a limited amount of 
evidence was obtained which may indicate that some of the extra-
cellular enzymatic activity may be associated with membranous mater-
ial. Approximately 1/3 of the culture fluid activator activity could 
be sedimented by a 1 hour centrifugation at 100,000 g and the sedimen-
tation of this material was prevented by the addition of 0.5% 
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Triton X 100. The distruptive action of detergents on cell membranes 
is well known and this could account for the altered sedimentation 
properties of extracellular activator when Triton X 100 was added. 
Christman et al. [20] have also reported that the cellular 
activator from SV4D transformed hamster fibroblasts was associated 
with the plasma membrane. However, Unkeless et aL [17] have em-
ployed differential centrifugation of intracellular material and 
suggested that the activator present in Rous sarcoma virus trans-
formed chick cells was localized in lysomal or microsomal fractions. 
These findings were somewhat surprising since these authors had pre-
viously demonstrated that no increases in the extracellular concen-
tration of various lysosmal enzymes were detected in the culture 
fluids of transformed cells which produced and/or released increased 
amounts of activator [3]. More recently, Quigley [43] has re-
ported that the cellular activator from RSV transformed chick fibro-
blasts was associated with plasma membrane or plasma membrane-like 
elements. In his communication he demonstrated that an activator 
from transformed chick cells co-purified with material which 
appeared to be membranous in electron micrographs and with molecules 
commonly reported to be associated with the plasma membrane. It is 
not known whether the activators from Hpa-6, Rous sarcoma virus trans-
formed chick, and SV40 transformed hamster cells are associated with 
the surface membrane or other internal and membranous organelles. 
Authors have suggested that proteases could be involved in the 
alterations of some surface properties which are ascribed to trans-
formed cells and it is possible that the actions of plasminogen 
activators could be responsible for some surface alterations 
(see reviews by Roblin et al. [44] and Hynes [11]). Yet, attempts 
to detect loss of cell surface material following the addition 
90 
of fluids containing plasminogen activator have been unsuccessful 
[20,41] and protein substrates other than plasmin have not been 
identified for any of the activators described. Since the activator 
is produced by a wide variety of cells it is also possible that it 
is involved in some common yet undefined cellular process, i.e., 
glycoprotein secretion, protein turnover, or modification of the 
newly synthesized proteins. Certainly, the membrane association 
could be studied in more detail and the results of such investigation 
could help to elucidate the biological function of some plasminogen 
activators. 
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